Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee

Biology of Sex Differences

Wendy M Kohrt¹  Richard D Coutts¹  Mary I O’Connor²  Laura L Tosi¹  C Kent Kwoh⁴  Kathleen A Sluka¹  Karen J Berkley¹  Eileen Resnick¹  Daniel P Nicolella¹  Roger M Enoka¹  David A Hart¹  Barbara D Boyan³ 

[1]Isis Research Network on Musculoskeletal Health, Society for Women’s Health Research, 1025 Connecticut Avenue, NW Suite 601, Washington, DC, 20036, USA

[2]Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida, USA

[3]Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, GA 30332-0363, USA

[4]Epidemiology, and Clinical and Translational Science Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, Pittsburgh, USA

关键词: Testosterone;    Tendon;    Sex steroids;    Sex differences;    Osteoarthritis;    Ligaments;    Estrogen;    Bone;   

Others  :  793314
DOI  :  10.1186/2042-6410-4-3

 received in 2012-07-12, accepted in 2012-12-10,  发布年份 2013

【 摘 要 】

Young female athletes experience a higher incidence of ligament injuries than their male counterparts, females experience a higher incidence of joint hypermobility syndrome (a risk factor for osteoarthritis development), and post-menopausal females experience a higher prevalence of osteoarthritis than age-matched males. These observations indicate that fluctuating sex hormone levels in young females and loss of ovarian sex hormone production due to menopause likely contribute to observed sex differences in knee joint function and risk for loss of function. In studies of osteoarthritis, however, there is a general lack of appreciation for the heterogeneity of hormonal control in both women and men. Progress in this field is limited by the relatively few preclinical osteoarthritis models, and that most of the work with established models uses only male animals. To elucidate sex differences in osteoarthritis, it is important to examine sex hormone mechanisms in cells from knee tissues and the sexual dimorphism in the role of inflammation at the cell, tissue, and organ levels. There is a need to determine if the risk for loss of knee function and integrity in females is restricted to only the knee or if sex-specific changes in other tissues play a role. This paper discusses these gaps in knowledge and suggests remedies.

【 授权许可】

   
2013 Boyan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Koelling S, Miosge N: Sex differences in chondrogenic progenitor cells in late stages of osteoarthritis. Arthritis Rheum 2010, 62:1077-1087.
• [2]Raz P, Nasatzky E, Boyan BD, Ornoy A, Schwartz Z: Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1. J Cell Biochem 2005, 95:108-119.
• [3]Beato M, Klug J: Steroid hormone receptors: an update. Hum Reprod Update 2000, 6:225-236.
• [4]Sun YH, Gao X, Tang YJ, Xu CL, Wang LH: Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 2006, 27:671-678.
• [5]Gatson JW, Kaur P, Singh M: Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endrocinology 2006, 147:2028-2034.
• [6]ElBaradie K, Wang Y, Boyan BD, Schwartz Z: Rapid membrane responses to dihydrotestosterone are sex dependent in growth plate chondrocytes. J Steroid Biochem Mol Biol 2012, 132:1-23.
• [7]Kinney RC, Schwartz Z, Week K, Lotz MK, Boyan BD: Human articular chondrocytes exhibit sexual dimorphism in their responses to 17beta-estradiol. Osteoarthritis Cartiilage 2005, 13:330-337.
• [8]McMillan J, Fatehi-Sedeh S, Sylvia VL, Bingham V, Zhong M, Boyan BD, Schwartz Z: Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways. Biochim Biophys Acta 2006, 1763:381-392.
• [9]Chaban VV, Lakhter AJ, Micevych P: A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004, 145:3788-3795.
• [10]Safe S, Kim K: Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008, 41:263-275.
• [11]Bonnelye E, Laurin N, Jurdic P, Hart DA, Aubin JE: Estrogen receptor-related receptor-alpha (ERR-alpha) is dysregulated in inflammatory arthritis. Rheumatology 2008, 47:1785-1791.
• [12]Achari Y, Lu T, Katzenellenbogen BS, Hart DA: Distinct roles for AF-1 and −2 of ER-alpha in regulation of MMP-13 promoter activity. Biochim Biophys Acta 2009, 1792:211-220.
• [13]Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER: Plasma membrane estrogen receptors exist and functions as dimers. Molecular Endocrinol 2004, 18:2854-2865.
• [14]Levin ER: Rapid signaling by steroid receptors. Amer J Physiol 2008, 295:R1425-R1430.
• [15]Sylvia VL, Dombroski D, Gay I, Dean DD, Schwartz Z, Boyan BD: Local production of estradiol by growth plate chondrocytes and its gender-specific membrane mediated effects. In Growth Plate. Edited by Shapiro IM, Boyan B, Anderson HC. Amsterdam: I O S Press; 2002:53-62. [Biomedical and Health Research]
• [16]Kampa M, Pelekanou V, Castanas E: Membrane-initiated steroid action in breast and prostate cancer. Steroids 2008, 73:953-960.
• [17]Kinney RC, Schwartz Z, Week K, Lotz MK, Boyan BD: Human articular chondrocytes exhibit sexual dimorphism in their responses to 17beta-estradiol. Osteoarthritis Cartilage 2005, 13:330-337.
• [18]Nasatzky E, Schwartz Z, Soskolne WA, Brooks BP, Dean DD, Boyan BD, Ornoy A: Evidence for receptors specific for 17beta-estradiol and testosterone in chondrocyte cultures. Connect Tissue Res 1994, 30:277-294.
• [19]Li XF, Wang SJ, Jiang LS, Dai LY: Gender- and region-specific variations of estrogen receptor alpha and beta expression in the growth plate of spine and limb during development and adulthood. Histochem Cell Biol 2012, 137:79-95.
• [20]Papakonstanti EA, Kampa M, Castanas E, Stournaras C: A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Molecular Endocrinol 2003, 17:870-881.
• [21]Vicencio JM, Ibarra C, Estrada M, Chiong M, Soto D, Parra V, Diaz-Araya G, Jaimovich E, Lavandero S: Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006, 147:1386-1395.
• [22]Sato SM, Johansen JA, Jordan CL, Wood RI: Membrane androgen receptors may mediate androgen reinforcement. Psychoneuroendocrinology 2010, 35:1063-1073.
• [23]Hu R, Dunn TA, Wei SZ, Isharwal S, Veltri RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB, Bova GS, Luo J: Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res 2009, 69:16-22.
• [24]Guo ZY, Yang X, Sun F, Jiang RC, Linn DE, Chen HG, Kong XT, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y: A novel androgen receptor splice variant Is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res 2009, 69:2305-2313.
• [25]Lovering RM, Romani WA: Effect of testosterone on the female anterior cruciate ligament. Amer J Physiol 2005, 289:R15-R22.
• [26]Elbaradie K, Wang Y, Boyan BD, Schwartz Z: Rapid membrane responses to dihydrotestosterone are sex dependent in growth plate chondrocytes. J Steroid Biochem Mol Biolin press
• [27]Turgeon JL, Waring DW: Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and L beta T2 gonadotropes. J Endocrinol 2006, 190:837-846.
• [28]Konduri S, Schwarz RE: Estrogen receptor beta alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. J Surg Res 2007, 140:55-66.
• [29]Peluso JJ: Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer. Steroids 2011, 76:903-909.
• [30]Park SK, Stefanyshyn DJ, Ramage B, Hart DA, Ronsky JL: Alterations in knee joint laxity during the menstrual cycle in healthy women leads to increases in joint loads during selected athletic movements. Am J Sports Med 2009, 37:1169-1177.
• [31]Vico L, Vanacker JM: Sex hormones and their receptors in bone homeostasis: insights from genetically modificed mouse models. Osteoporos Int 2010, 21:365-372.
• [32]Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S: Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 1999, 7:560-566.
• [33]Kydd AS, Reno CR, Tsao HW, Hart DA: Early inflammatory arthritis in the rabbit: the influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissues of the knee. J Rheumatol 2007, 34:130-139.
• [34]Bray RC, Fisher AW, Frank CB: Fine vascular anatomy of adult rabbit knee ligaments. J Anatomy 1990, 172:69-79.
• [35]Labrie F: Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol 2003, 64:95-107.
• [36]Mestre-Alfaro A, Ferrer MD, Sureda A, Tauler P, Martinez E, Bibiloni MM, Micol V, Tur JA, Pons A: Phytoestrogens enhance antioxidant enzymes after swimming exercise and modulate sex hormone plasma levels in female swimmers. Euro J Appl Physiol 2011, 111:2281-2294.
• [37]Diez-Perez A: Selective estrogen receptor modulators (SERMS). Arquivos Brasileiros de Endocrinologia e Metabologia 2006, 50:720-734.
• [38]Lu WJ, Desta Z, Flockhart DA: Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer. Breast Cancer Res Treatment 2012, 131:473-481.
• [39]Treeck O, Pfeiler G, Mitter D, Lattrich C, Piedl G, Ortmann O: Estrogen receptor-beta1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinology 2007, 193:421-433.
• [40]van der Meij L, Almeda M, Buunk AP, Fawcett TW, Salvador A: Men with elevated testosterone levels show more afilliative behaviours during interactions with women. Proc Biol Sci 2012, 279:202-208.
• [41]Sylvia VL, Gay I, Hardin R, Dean DD, Boyan BD, Schwartz Z: Rat costochondral chondrocytes produce 17beta-estradiol and regulate its production by 1alpha,25(OH)(2)D(3). Bone 2002, 30:57-63.
• [42]Linn S, Murtaugh B, Casey E: Role of sex hormones in the development of osteoarthritis. PM R 4(Suppl):169-173.
• [43]Takeuchi S, Mukai N, Tateishi T, Miyakawa S: Production of sex steroid hormones from DHEA in articular chondrocyte of rats. Am J Physiol 2007, 293:E410E415.
• [44]Shiozawa T, Shih HC, Miyamoto T, Feng YZ, Uchikawa J, Itoh K, Konishi I: Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 2003, 88:871-878.
• [45]Arendt EA, Agel J, Dick R: Anterior cruciate ligament injury patterns among collegiate men and women. J Athletic Training 1999, 34:86-92.
• [46]Arendt EA: Musculoskeletal injuries of the knee: are females at greater risk? Minnesota Med 2007, 90:38-40.
• [47]Arendt EA: Gender differences in musculoskeletal health. J Gender-Specific Med 2000, 3:58-64.
• [48]Wentorf FA, Sudoh K, Moses C, Arendt EA, Carlson CS: The effects of estrogen on material and mechanical properties of the intra- and extra-articular knee structures. Am J Sports Med 2006, 34:1948-1952.
• [49]Kupper JC, Loitz-Ramage B, Corr DT, Hart DA, Ronsky JL: Measuring knee joint laxity: a review of applicable models and the need for new approaches to minimize variability. Clin Biomech 2007, 22:1-13.
• [50]Zazulak BT, Paterno M, Myer GD, Romani WA, Hewett TE: The effects of the menstrual cycle on anterior knee laxity: a systematic review. Sports Med 2006, 36:847-862.
• [51]Park SK, Stefanyshyn DJ, Loitz-Ramage B, Hart DA, Ronsky JL: Changing hormone levels during the menstrual cycle affect knee laxity and stiffness in healthy female subjects. Am J Sports Med 2009, 37:588-598.
• [52]Park SK, Stefanyshyn DJ, Ramage B, Hart DA, Ronsky JL: Relationship between knee joint laxity and knee joint mechanics during the menstrual cycle. Brit J Sports Med 2009, 43:174-179.
• [53]Myer GD, Ford KR, Khoury J, Succop P, Hewett TE: Development and validation of a clinic-based prediction tool to identify female athletes at high risk for anterior cruciate ligament injury. Am J Sports Med 2010, 38:2025-2033.
• [54]Hewett TE, Lynch TR, Myer GD, Ford KR, Gwin RC, Heidt RS: Jr: Multiple risk factors related to familial predisposition to anterior cruciate ligament injury: fraternal twin sisters with anterior cruciate ligament ruptures. Brit J Sports Med 2010, 44:848-855.
• [55]Kessler MA, Behrend H, Henz S, Stutz G, Rukavina A, Kuster MS: Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment. Knee Surg Sports Traumatol Arthrosc 2008, 16:442-448.
• [56]Lohmander LS, Ostenberg A, Englund M, Roos H: High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum 2004, 50:3145-3152.
• [57]von Porat A, Roos EM, Roos H: High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes. Ann Rheum Dis 2004, 63:269-273.
• [58]Maffulli N, Longo UG, Gougoulias N, Loppini M, Denaro V: Long-term health outcomes of youth sports injuries. Brit J Sports Med 2010, 44:21-25.
• [59]Ageberg E, Forssblad M, Herbertsson P, Roos EM: Sex differences in patient-reported outcomes after anterior cruciate ligament reconstruction: data from the Swedish knee ligament register. Am J Sports Med 2010, 38:1334-1342.
• [60]Moller E, Weidenhielm L, Werner S: Outcome and knee-related quality of life after anterior cruciate ligament reconstruction: a long-term follow-up. Knee Surg Sports Traumatol Arthrosc 2009, 17:786-794.
• [61]Grahame R: Heritable disorders of connective tissue. Bailliere's Best Practice Res Clin Rheumatol 2000, 14:345-361.
• [62]Malfait F, Wenstrup RJ, De Paepe A: Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 2010, 12:597-605.
• [63]Zweers MC, Kucharekova M, Schalkwijk J: Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome? Ann Rheumat Dis 2005, 64:504-505.
• [64]Hakim AJ, Grahame R: Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Rheumatology 2004, 43:1194-1195.
• [65]Hakim AJ, Cherkas LF, Grahame R, Spector TD, MacGregor AJ: The genetic epidemiology of joint hypermobility: a population study of female twins. Arthritis Rheum 2004, 50:2640-2644.
• [66]Dolan AL, Hart DL, Doyle DV, Grahame R, Spector TD: The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study. Journal Rheumatology 2003, 30:799-803.
• [67]Tanamas SK, Wijethi P, Wluka AE, Davies-Tuck ML, Urquhart DM, Wang Y, Cicuttini FM: Sex hormones and structural changes in osteoarthritis: a systematic review. Maturitias 2011, 69:141-156.
• [68]Kinney R, Schwartz Z, Week K, Lotz M, Boyan B: Human articular chondrocytes exhibit sexual dimorphism in their responses to 17beta-estradiol. Osteoarthrit Cartilage 2005, 13:330-337.
• [69]Claassen H, Schicht M, Brandt J, Reuse K, Schadlich R, Goldring MB, Guddat SS, Thate A, Paulsen F: C-28/I2 and T/C-28a2 chondrocytes as well as human primary articular chondrocytes express sex hormone and insulin receptors--Useful cells in study of cartilage metabolism. Ann Anat Anatomischer Anzeiger 2011, 193:23-29.
• [70]Talwar RM, Wong BS, Svoboda K, Harper RP: Effects of estrogen on chondrocyte proliferation and collagen synthesis in skeletally mature articular cartilage. J Oral Maxillofac Surg 2006, 64:600-609.
• [71]Breu A, Sprinzing B, Merkl K, Bechmann V, Kujat R, Jenei-Lanzl Z, Prantl L, Angele P: Estrogen reduces cellular aging in human mesenchymal stem cells and chondrocytes. J Orthop Res 2011, 29:1563-1571.
• [72]Claassen H, Steffen R, Hassenpflug J, Varoga D, Wruck CJ, Brandenburg LO, Pufe T: 17beta-estradiol reduces expression of MMP-1, -3, and −13 in human primary articular chondrocytes from female patients cultured in a three dimensional alginate system. Cell Tissue Res 2010, 342:283-293.
• [73]Takeuchi S, Mukai N, Tateishi T, Miyakawa S: Production of sex steroid hormones from DHEA in articular chondrocyte of rats. Amer J Physiol 2007, 293:E410-E415.
• [74]Nevitt MC, Felson DT: Sex hormones and the risk of osteoarthritis in women: epidemiological evidence. Ann Rheumat Dis 1996, 55:673-676.
• [75]Sniekers YH, Weinans H, Bierma-Zeinstra SM, van Leeuwen JP, van Osch GJ: Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach. Osteoarthrit Cartilage 2008, 16:533-541.
• [76]Grandin HM, Gemperli AC, Dard M: Enamel Matrix Derivative. A review of cellular effects in vitro and a model of molecular arrangement and functioning. Tissue Engin Part B Revin press
• [77]Bertl K, An N, Bruckmann C, Dard M, Andrukhov O, Matejka M, Rausch-Fan X: Effects of enamel matrix derivative on proliferation/viability, migration, and expression of angiogenic factor and adhesion molecules in endothelial cells in vitro. J Periodontol 2009, 80:1622-1630.
• [78]Carinci F, Piattelli A, Guida L, Perrotti V, Laino G, Oliva A, Annunziata M, Palmieri A, Pezzetti F: Effects of Emdogain on osteoblast gene expression. Oral Dis 2006, 12:329-342.
• [79]Yao W, Balooch G, Balooch M, Jiang Y, Nalla RK, Kinney J, Wronski TJ, Lane NE: Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. Bone 2006, 39:460-469.
• [80]McMillan J, Kinney RC, Ranly DM, Fatehi-Sedeh S, Schwartz Z, Boyan BD: Osteoinductivity of demineralized bone matrix in immunocompromised mice and rats is decreased by ovariectomy and restored by estrogen replacement. Bone 2007, 40:111-121.
• [81]Heer M, Kamps N, Biener C, Korr C, Boerger A, Zittermann A, Stehle P, Drummer C: Calcium metabolism in microgravity. Eur J Med Res 1999, 4:357-360.
• [82]Hart DA, Scott A: Getting the dose right when prescribing exercise for connective tissue conditions: the Ying and the Yang of tissue homeostasis. Brit J Sports Medin press
• [83]Goldring MB, Goldring SR: Articular cartilage and subchondral bone in the pathophysiology of osteoarthritis. Ann New York Acad Sci 2010, 1192:230-237.
• [84]Ding M: Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues. Acta Orthopaedica Suppl 2010, 81:1-53.
• [85]Hanna FS, Teichtahl AJ, Wluka AE, Wang Y, Urquhart DM, English DR, Giles GG, Cicuttini FM: Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: a gender study of adults without clinical knee osteoarthritis. Menopause 2009, 16:666-670.
• [86]Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247.
• [87]Goldring MB, Otero M: Inflammation in osteoarthritis. Curr Opinion Rheumatol 2011, 23:471-478.
• [88]Marriott I, Huet-Hudson YM: Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 2006, 34:177-192.
• [89]Pfeilschifter J, Koditz R, Pfohl M, Schatz H: Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002, 23:90-119.